The impact of PET/CT on therapeutic strategy of patients with colorectal cancer metastasis

Hepato-Gastroenterology

Volumn 56, Issue 93, 2009, Pages 968-970

  Liu, Yan Nan ^a   Huang, Mei Xiong ^a   An, Qi ^a   Wei, Jun Min ^a  

^a BEIJING HOSPITAL   (China)

Author keywords

18F fluorodeoxy glucose; Colorectal cancer; Computed tomography; Contrast enhanced computed tomography; Metastasis; Positron emission tomography

Indexed keywords

FLUORODEOXYGLUCOSE F 18; CONTRAST MEDIUM;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COLON RESECTION; COLORECTAL CANCER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTRAST ENHANCEMENT; FEMALE; FOLLOW UP; HUMAN; LIVER METASTASIS; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; COLORECTAL TUMOR; COMPUTER ASSISTED TOMOGRAPHY; METASTASIS; METHODOLOGY; MIDDLE AGED; PATHOLOGY; RADIOGRAPHY; SCINTISCANNING;

ADULT; AGED; COLORECTAL NEOPLASMS; CONTRAST MEDIA; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 70350490173     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Dorudi S, Steele RJ, McArdle CS: Surgery for colorectal cancer. Br Med Bull 2002; 64: 101-118. (Pubitemid 35238582)
2. Guillem JG, Chessin DB, Cohen AM, et al.: Long-term oncologic outcome following preoperative combined modality therapy and total mesorectal excision of locally advanced rectal cancer. Ann Surg 2005; 241:829-836.
3. Manfredi S, Lepage C, Hatem C, et al.: Epidemiology and management of liver metastases from colorectal cancer. Ann Surg 2006; 244:254-259. (Pubitemid 44305540)
4. Even-Sapir E, Parag Y, Lerman H,et al: Detection of recurrence in patients with rectal cancer: PET/CT after abdominoperineal or anterior resection. Radiology 2004; 232:815-822. (Pubitemid 39100268)
5. Selzner M, Hany TF, Wildbrett P, et al.: Does the Novel PET/CT Imaging Modality Impact on the Treatment of Patients With Metastatic Colorectal Cancer of the Liver? Ann Surg 2004; 240:1027-1034.
6. Shen YY, Hang JA, Chen YK, et al.: Clinical impact of 18F-FDG-PET in the suspicion of recurrent colorectal cancer based on asymptomatically elevated serum level of carcinoembryonic antigen (CEA) in Taiwan. Hepatogastroenterology 2006; 53:348-350.
7. Fernandez FG, Drebin JA, Linehan DC, et al.: Fiveyear survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET). Ann Surg 2004; 240:438-447.
8. Joyce DL, Wahl RL, Patel PV, et al.: Preoperative positron emission tomography to evaluate potentially resectable hepatic colorectal metastases. Arch Surg 2006; 141:1220-1226. (Pubitemid 44956639)
9. Park IJ, Kim HC, Yu CS, et al.: Efficacy of PET/CT in the accurate evaluation of primary colorectal carcinoma. Eur J Surg Oncol 2006; 32:941-947. (Pubitemid 44739687)